These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28647445)

  • 1. The Value of Anti-Müllerian Hormone in Predicting Clinical Pregnancy After Intrauterine Insemination.
    Dondik Y; Virji N; Butler TS; Gaskins JT; Pagidas K; Sung L
    J Obstet Gynaecol Can; 2017 Oct; 39(10):880-885. PubMed ID: 28647445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can anti-Mullerian hormone (AMH) predict the outcome of intrauterine insemination with controlled ovarian stimulation?
    Bakas P; Boutas I; Creatsa M; Vlahos N; Gregoriou O; Creatsas G; Hassiakos D
    Gynecol Endocrinol; 2015 Oct; 31(10):765-8. PubMed ID: 26288100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can anti-Müllerian hormone predict success outcomes in donor sperm inseminations?
    González-Foruria I; Martínez F; Rodríguez-Purata J; Ballester M; Alonso-Mosquera V; Buxaderas R; Rodríguez I; Coroleu B
    Gynecol Endocrinol; 2019 Jan; 35(1):40-43. PubMed ID: 30324829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of serum Anti-Mullerian Hormone levels on the results of assisted reproductive technologies. Single-center retrospective study from 2011 cycles (ICSI and bilateral tubal obstruction excluded)].
    Dosso N; Robin G; Catteau-Jonard S; Pigny P; Leroy-Billiard M; Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2015 Jan; 44(1):63-71. PubMed ID: 24951378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance between day-3 follicle stimulating hormone & anti-Müllerian hormone is predictive of clinical pregnancy during fertility treatment.
    Butler WJ; Pico A; Hawkins KC; Younis AI
    Gynecol Endocrinol; 2021 Sep; 37(9):798-801. PubMed ID: 33355011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman's age and markers of ovarian reserve.
    Di Paola R; Garzon S; Giuliani S; Laganà AS; Noventa M; Parissone F; Zorzi C; Raffaelli R; Ghezzi F; Franchi M; Zaffagnini S
    Arch Gynecol Obstet; 2018 Nov; 298(5):1029-1035. PubMed ID: 30242498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of anti-Müllerian hormone in prediction of pregnancy in young and older women with unexplained infertility undergoing intrauterine insemination.
    Seckin B; Tokmak A; Yumusak OH
    J Chin Med Assoc; 2019 Apr; 82(4):300-304. PubMed ID: 30946209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A higher anti-Müllerian hormone level is associated with an increased chance of pregnancy in patients undergoing controlled ovarian stimulation and intrauterine insemination.
    Wang MH; Chen CH; Wang CW; Hsu MI; Tzeng CR
    J Obstet Gynaecol; 2015 Jan; 35(1):64-8. PubMed ID: 25010731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve.
    Tiegs AW; Sun L; Scott RT; Goodman LR
    Fertil Steril; 2020 Apr; 113(4):788-796.e4. PubMed ID: 32147173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination.
    Moro F; Tropea A; Scarinci E; Leoncini E; Boccia S; Federico A; Alesiani O; Lanzone A; Apa R
    Int J Gynaecol Obstet; 2016 Apr; 133(1):64-8. PubMed ID: 26873125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of in vitro fertilization versus intrauterine insemination in patients with low anti-Müllerian hormone levels. A single-center retrospective study of 639 + 119 cycles.
    Sapet C; Gavoille A; Sesques A; Freour T; Subtil F; Salle B
    J Gynecol Obstet Hum Reprod; 2021 Mar; 50(3):101874. PubMed ID: 32687891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone does not predict cumulative pregnancy rate in non-infertile women following four IUI cycles with donor sperm.
    Gayete-Lafuente S; Moreno-Sepulveda J; Sánchez-Álvarez J; Prat M; Robles A; Espinós JJ; Checa MÁ
    J Assist Reprod Genet; 2024 Jul; ():. PubMed ID: 38987421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A; Abdelmeged A; El-Adawy AR; Eissa MK; Shaw RW; Amer SA
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the outcome of intrauterine insemination (IUI): age, clinical variables and significant thresholds.
    Speyer BE; Abramov B; Saab W; Doshi A; Sarna U; Harper JC; Serhal P
    J Obstet Gynaecol; 2013 Oct; 33(7):697-700. PubMed ID: 24127958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intra-uterine insemination outcomes according to the serum AMH level on day 3].
    Lamazou F; Fuchs F; Genro V; Malagrida L; Torre A; Albert M; Wainer R
    J Gynecol Obstet Biol Reprod (Paris); 2012 Apr; 41(2):122-7. PubMed ID: 21962540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy.
    Tremellen K; Kolo M
    Aust N Z J Obstet Gynaecol; 2010 Dec; 50(6):568-72. PubMed ID: 21133869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.